力生制药氨茶碱片通过仿制药一致性评价

Core Viewpoint - Lisheng Pharmaceutical has received approval from the National Medical Products Administration for its 0.1g specification of Aminophylline tablets, which have passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1: Product Approval - The approval notification pertains to Aminophylline tablets, which are indicated for the relief of symptoms in bronchial asthma, asthmatic bronchitis, and obstructive pulmonary emphysema [1] - The drug is also applicable for asthma caused by cardiogenic pulmonary edema [1]